1.32
+0.005(+0.38%)
Currency In USD
| Previous Close | 1.31 |
| Open | 1.31 |
| Day High | 1.34 |
| Day Low | 1.31 |
| 52-Week High | 2.55 |
| 52-Week Low | 1.13 |
| Volume | 9,146 |
| Average Volume | 27,182 |
| Market Cap | 64.5M |
| PE | -5.26 |
| EPS | -0.25 |
| Moving Average 50 Days | 1.32 |
| Moving Average 200 Days | 1.63 |
| Change | 0.01 |
If you invested $1000 in MediciNova, Inc. (MNOV) 10 years ago, it would be worth $373.58 as of August 18, 2025 at a share price of $1.315. Whereas If you bought $1000 worth of MediciNova, Inc. (MNOV) shares 5 years ago, it would be worth $225.56 as of August 18, 2025 at a share price of $1.315.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million
GlobeNewswire Inc.
Jul 31, 2025 11:30 PM GMT
LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces a
MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials
GlobeNewswire Inc.
Jul 24, 2025 10:00 AM GMT
MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes patients requires final two patientsLA JOLLA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutica
MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
GlobeNewswire Inc.
Apr 14, 2025 11:00 PM GMT
LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces that their